[Analysis of transmission of Burkholderia cepacia isolates in an intrahospital by randomly amplified polymorphic DNA-PCR method].

Strains of Burkholderia cepacia isolated in our hospital from November 1995 to September 1996 were classified with randomly amplified polymorphic DNA-PCR (RAPD-PCR) and conventional biochemical tests (ID test.NF-18, API20NE, and Neg Combo 4J kit), and intrahospital isolates of B. cepacia were analysed. During the period 28 strains from inpatients and 2 from medical apparatus were isolated. Twenty four of 28 (85.7%) were from sputum. In 1996 from January to February, 20 strains were detected from 8 inpatients, and two strains were from the nebulizers at the Trauma and Critical Care Center (TCC). With typing of B. cepacia by conventional methods no epidemiological relations among isolates were found. However, DNA patterns of original isolates from the nebulizers at TCC by RAPD-PCR were identical with those of isolates in sputa from patients in other wards who had stayed at TCC, indicating that TCC was an initial source of transmission and the strain was transmitted with the patients to the wards. These results suggest that RAPD-PCR method might be a useful tool to analyse an epidemiological survey for intrahospital transmission of isolate.

[1]  R. Anthony,et al.  Analysis of an outbreak of non-phage-typeable methicillin-resistant Staphylococcus aureus by using a randomly amplified polymorphic DNA assay , 1997, Journal of Clinical Microbiology.

[2]  M E Campbell,et al.  Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting , 1996, Journal of clinical microbiology.

[3]  P. Rohrlich,et al.  Molecular epidemiology provides evidence of genotypic heterogeneity of multidrug-resistant Pseudomonas aeruginosa serotype O:12 outbreak isolates from a pediatric hospital , 1996, Journal of clinical microbiology.

[4]  D. Pegues,et al.  Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak , 1996, Epidemiology and Infection.

[5]  R. Spencer The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. , 1995, The Journal of hospital infection.

[6]  N. Høiby Isolation and treatment of cystic fibrosis patients with lung infections caused by Pseudomonas (Burkholderia) cepacia and multiresistant Pseudomonas aeruginosa. , 1995, The Netherlands journal of medicine.

[7]  Eric J. Houston,et al.  An Outbreak of Burkholderia (Formerly Pseudomonas) cepacia Respiratory Tract Colonization and Infection Associated with Nebulized Albuterol Therapy , 1995, Annals of Internal Medicine.

[8]  D. Pegues,et al.  Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis. , 1994, Archives of pediatrics & adolescent medicine.

[9]  D. Anderson,et al.  DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak , 1991, Journal of clinical microbiology.

[10]  W. Martone,et al.  Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. , 1989, Reviews of infectious diseases.

[11]  J. Sobel,et al.  Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. , 1982, The American journal of medicine.

[12]  L. T. Stauffer,et al.  Construction and expression of hybrid plasmids containing the Escherichia coli glyA genes. , 1981, Gene.

[13]  Rosenstein Bj,et al.  Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis. , 1980 .